How 23AndMe Went From a $6 Billion Valuation to a Penny Stock
Wall Street Journal
DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have knocked the company’s share price down to nearly $0.
https://www.wsj.com/articles/how-23andme-went-from-a-6-billion-valuation-to-a-penny-stock-66a1ce15